**Core Concept:** Alcohol dependence is a chronic disorder characterized by compulsive alcohol consumption, withdrawal symptoms, and continued use despite adverse consequences. Pharmacotherapy plays a crucial role in managing alcohol dependence, targeting various aspects of the disease.

**Why the Correct Answer is Right:** Nalmefene (Option C) is a selective opioid receptor antagonist that works by blocking the effects of endogenous opioids released during alcohol consumption, thereby reducing craving and alcohol intake. It is also effective in reducing alcohol withdrawal symptoms.

**Why Each Wrong Option is Incorrect:**

A. Acamprosate (Option B) is another pharmacologic agent used in the management of alcohol dependence, acting on the gamma-aminobutyric acid (GABA) system and the NMDA glutamate receptor system to reduce alcohol craving and withdrawal symptoms.

B. Disulfiram (Option A) is a widely used drug for alcohol dependence, causing an unpleasant reaction when alcohol is consumed, which acts as a deterrent for alcohol intake. It is not a selective antagonist like nalmefene and acamprosate, targeting various neurotransmitter systems.

C. Naltrexone (Option D) is another opioid receptor antagonist, similar to nalmefene, but it is used for pain management and is not approved for alcohol dependence treatment.

D. Chlorpheniramine (Option D) is an antihistamine used in the management of allergic disorders and is not used for alcohol dependence.

**Clinical Pearl:** Nalmefene is an effective and well-tolerated medication for alcohol dependence, especially in patients who have experienced severe withdrawal symptoms or craving. It is often used in combination with psychosocial interventions for optimal treatment outcomes.